Sandbox p: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Label template | {{Label template | ||
|authorTag=; {{AE}} {{JH}} | |authorTag=; {{AE}} {{JH}} |
Latest revision as of 12:41, 21 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]
For information about metoprolol, click here.
Disclaimer
Overview
Sandbox p is a Beta-adrenergic agonist drug that is FDA approved for the treatment of Hypertension, AMI, Angina. Adverse reactions include Here are some adverse reactions.